These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 4678208)

  • 1. The stimulatory effect on insulin secretion in long-term tolbutamide treatment. Immunological determinations of urinary- and serum insulin.
    Johansen K; Orskov H
    Acta Endocrinol (Copenh); 1972 Dec; 71(4):709-15. PubMed ID: 4678208
    [No Abstract]   [Full Text] [Related]  

  • 2. Circadian variation of glucose, insulin, and free fatty acids during long-term use of oral hypoglycaemic agents in diabetes mellitus.
    Rigas AN; Bittles AH; Hadden DR; Montgomery DA
    Br Med J; 1968 Oct; 4(5622):25-8. PubMed ID: 5677210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of long-term tolbutamide treatment on glucose tolerance and insulin secretion in maturity-onset diabetes without obesity.
    Lauvaux JP; Mandart G; Heymans G; Ooms HA
    Horm Metab Res; 1972 Mar; 4(2):58-62. PubMed ID: 5028221
    [No Abstract]   [Full Text] [Related]  

  • 4. [Diminution of delay in insulin secretion in early diabetes mellitus with ongoing tolbutamide treatment].
    Nadeau A; Catellier C
    Union Med Can; 1974 Mar; 103(3):413-7. PubMed ID: 4820869
    [No Abstract]   [Full Text] [Related]  

  • 5. [Contribution to the nutrition-dependent release of insulin in obese maturity-onset diabetics].
    Beringer A; Waldhäusl W
    Acta Diabetol Lat; 1968; 5(4):566-79. PubMed ID: 5720636
    [No Abstract]   [Full Text] [Related]  

  • 6. [Blood sugar, serum insulin, nonesterified fatty acids and somatotropin in daily profile in adult diabetics under monotherapy with various sulfonylureas].
    Happ J; Beyer J; Nest E; Fröhlich A; Althoff PH; Schöffling K
    Arzneimittelforschung; 1974 Aug; 24(8):1228-34. PubMed ID: 4214173
    [No Abstract]   [Full Text] [Related]  

  • 7. Differential effects of tolbutamide on first and second phase insulin secretion in noninsulin-dependent diabetes mellitus.
    Pfeifer MA; Halter JB; Beard JC; Porte D
    J Clin Endocrinol Metab; 1981 Dec; 53(6):1256-62. PubMed ID: 7028776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mild diabetes mellitus in children and young adults. Clinical features and endogenous insulin response].
    Johansen K
    Nord Med; 1968 Aug; 80(33):1080-3. PubMed ID: 5685664
    [No Abstract]   [Full Text] [Related]  

  • 9. Administration of sulfonylureas can increase glucose-induced insulin secretion for decades in patients with maturity-onset diabetes of the young.
    Fajans SS; Brown MB
    Diabetes Care; 1993 Sep; 16(9):1254-61. PubMed ID: 8404429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No effect of propranolol and metoprolol on tolbutamide-stimulated insulin-secretion in hypertensive diabetic and non-diabetic patients.
    Tötterman KJ; Groop LC
    Ann Clin Res; 1982 Aug; 14(4):190-3. PubMed ID: 6762846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A method of studying insulin secretion in humans: the glucose stimulation test, followed by tolbutamide].
    Vague P; Ramahandridona G; Vialettes B
    Nouv Presse Med; 1976 Dec; 5(4):3001-4. PubMed ID: 794823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circadian variations of carbohydrate tolerance in maturity onset diabetics treated with sulfonylureas.
    Göschke H; Denes A; Girard J; Collard F; Berger W
    Horm Metab Res; 1974 Sep; 6(5):386-91. PubMed ID: 4417576
    [No Abstract]   [Full Text] [Related]  

  • 13. Plasma hydroxycorticosteroids circadian rhythm in diabetic adult subjects under different types of treatment.
    Serio M; Della Corte M; Piolanti P; Romano S; Giglioli L; Giusti G
    Ann Endocrinol (Paris); 1971; 32(3):403-8. PubMed ID: 5114905
    [No Abstract]   [Full Text] [Related]  

  • 14. Therapeutic effect of tolbutamide in non-insulin dependent diabetes mellitus (NIDDM). Relation to beta-cell function.
    Damsgaard EM; Faber O; Frøland A; Iversen S
    Acta Endocrinol (Copenh); 1982 Jul; 100(3):416-20. PubMed ID: 7051723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of short-term tolbutamide treatment on insulin dynamics in newly diagnosed obese and non-obese adult diabetics.
    Wajchenberg BL; Nakasone K; Pasternak K
    Horm Metab Res; 1970 Jan; 2(1):6-8. PubMed ID: 5520756
    [No Abstract]   [Full Text] [Related]  

  • 16. Some aspects of circadian variations of carbohydrate metabolism and related hormones in man.
    Sensi S
    Chronobiologia; 1974; 1(4):396-404. PubMed ID: 4619798
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of short and long term chlorpropamide treatment of insulin release and blood-glucose.
    Barnes AJ; Garbien KJ; Crowley MF; Bloom A
    Lancet; 1974 Jul; 2(7872):69-72. PubMed ID: 4136696
    [No Abstract]   [Full Text] [Related]  

  • 18. Offspring of two diabetic parents: differential serum insulin responses to intravenous glucose and tolbutamide.
    Rojas L; Soeldner JS; Gleason RE; Kahn CB; Marble A
    J Clin Endocrinol Metab; 1969 Dec; 29(12):1569-79. PubMed ID: 4899852
    [No Abstract]   [Full Text] [Related]  

  • 19. Maximum stimulation of insulin secretion in children with chemical diabetes and obesity.
    Castells S; Avruskin T; Reddy CM; Hashemi SE
    Am J Med Sci; 1976; 271(1):35-9. PubMed ID: 943938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diurnal change of plasma insulin in diabetics with sulfonylurea treatment.
    Toyota T
    Tohoku J Exp Med; 1969 Aug; 98(4):345-56. PubMed ID: 5346206
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.